Developments in advanced prostate cancer in 2016

Martin J P Hennig; Nils Gilbert; Axel S. Merseburger

Developments in advanced prostate cancer in 2016

Martin J P Hennig, Nils Gilbert, Axel S. Merseburger^*

^*Corresponding author for this work

Department of Urology

Abstract

As we have experienced before, the diagnostic and therapeutic landscape is transient and rapidly evolving, especially in regards to advanced prostate cancer (PC). As practical clinicians and care providers we must not just stay in touch with the latest developments in the field but anticipate the needs of our clientele and patients. This editorial will provide a brief summary of the latest ground-breaking developments with clinical impact in the field of prostate cancer.

Original language	English
Journal	European Oncology and Haematology
Volume	12
Issue number	1
Pages (from-to)	17-18
Number of pages	2
ISSN	2045-5275
Publication status	Published - 01.06.2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{eab9b93d50da490da1aa873d36dc9525,

title = "Developments in advanced prostate cancer in 2016",

abstract = "As we have experienced before, the diagnostic and therapeutic landscape is transient and rapidly evolving, especially in regards to advanced prostate cancer (PC). As practical clinicians and care providers we must not just stay in touch with the latest developments in the field but anticipate the needs of our clientele and patients. This editorial will provide a brief summary of the latest ground-breaking developments with clinical impact in the field of prostate cancer.",

author = "Hennig, \{Martin J P\} and Nils Gilbert and Merseburger, \{Axel S.\}",

year = "2016",

month = jun,

day = "1",

language = "English",

volume = "12",

pages = "17--18",

journal = "European Oncology and Haematology",

issn = "2045-5275",

publisher = "Touch Briefings",

number = "1",

}

TY - JOUR

T1 - Developments in advanced prostate cancer in 2016

AU - Hennig, Martin J P

AU - Gilbert, Nils

AU - Merseburger, Axel S.

PY - 2016/6/1

Y1 - 2016/6/1

N2 - As we have experienced before, the diagnostic and therapeutic landscape is transient and rapidly evolving, especially in regards to advanced prostate cancer (PC). As practical clinicians and care providers we must not just stay in touch with the latest developments in the field but anticipate the needs of our clientele and patients. This editorial will provide a brief summary of the latest ground-breaking developments with clinical impact in the field of prostate cancer.

AB - As we have experienced before, the diagnostic and therapeutic landscape is transient and rapidly evolving, especially in regards to advanced prostate cancer (PC). As practical clinicians and care providers we must not just stay in touch with the latest developments in the field but anticipate the needs of our clientele and patients. This editorial will provide a brief summary of the latest ground-breaking developments with clinical impact in the field of prostate cancer.

UR - https://www.scopus.com/pages/publications/84970973859

M3 - Editorial

AN - SCOPUS:84970973859

SN - 2045-5275

VL - 12

SP - 17

EP - 18

JO - European Oncology and Haematology

JF - European Oncology and Haematology

IS - 1

ER -

Developments in advanced prostate cancer in 2016

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this